Research ArticleOriginal Article

LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214

Ying Chen, Hui Du, Lewen Bao and Wenxin Liu
Cancer Biology & Medicine August 2018, 15 (3) 238-250; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0174

References

  1. 1.↵
    2. Siegel RL,
    3. Miller KD,
    4. Jemal A.
    Cancer statistics, 2017. CA Cancer J Clin. 2017; 67: 7–30.
    OpenUrlCrossRefPubMed
  2. 2.↵
    2. Webb PM,
    3. Jordan SJ.
    Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2017; 41: 3–14.
    OpenUrlPubMed
  3. 3.↵
    2. Zietek A,
    3. Bogusiewicz M,
    4. Szumilo J,
    5. Rechberger T.
    Opportunistic salpingectomy for prevention of sporadic ovarian cancer - a jump from basic science to clinical practice?. Ginekol Pol. 2016; 87: 467–72.
    OpenUrl
  4. 4.↵
    2. Zheng Y,
    3. Liu L,
    4. Shukla GC.
    A comprehensive review of web-based non-coding RNA resources for cancer research. Cancer Lett. 2017; 407: 1–8.
    OpenUrl
  5. 5.↵
    2. Gulia C,
    3. Baldassarra S,
    4. Signore F,
    5. Rigon G,
    6. Pizzuti V,
    7. Gaffi M, et al.
    Role of Non-coding RNAs in the etiology of bladder cancer. Genes. 2017; 8: 339.
    OpenUrl
  6. 6.↵
    2. Romano G,
    3. Veneziano D,
    4. Acunzo M,
    5. Croce C M.
    Small non-coding RNA and cancer. Carcinogenesis. 2017; 38: 485–91.
    OpenUrlCrossRef
  7. 7.↵
    2. Chen Y,
    3. Zhang L.
    Members of the microRNA-200 family are promising therapeutic targets in cancer. Exp Ther Med. 2017; 14: 10–7.
    OpenUrl
  8. 8.↵
    2. Chen J,
    3. Wang R,
    4. Zhang K,
    5. Chen LB.
    Long non-coding RNAs in non-small cell lung cancer as biomarkers and therapeutic targets. J Cell Mol Med. 2014; 18: 2425–36.
    OpenUrl
  9. 9.↵
    2. Chen ZL,
    3. Yu C,
    4. Zhan L,
    5. Pan YZ,
    6. Chen L,
    7. Sun CY.
    LncRNA CRNDE promotes hepatic carcinoma cell proliferation, migration and invasion by suppressing miR-384. Am J Cancer Res. 2016; 6: 2299–309.
    OpenUrlPubMed
  10. 10.↵
    2. Hirata H,
    3. Hinoda Y,
    4. Shahryari V,
    5. Deng GR,
    6. Nakajima K,
    7. Tabatabai ZL, et al.
    Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205. Cancer Res. 2015; 75: 1322–31.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    2. Wan L,
    3. Sun M,
    4. Liu GJ,
    5. Wei CC,
    6. Zhang EB,
    7. Kong R, et al.
    Long noncoding RNA PVT1 Promotes Non-small cell lung cancer cell proliferation through epigenetically regulating LATS2 expression. Mol Cancer Ther. 2016; 15: 1082–94.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    2. Gou X,
    3. Zhao XY,
    4. Wang ZR.
    Long noncoding RNA PVT1 promotes hepatocellular carcinoma progression through regulating miR-214. Cancer Biomark. 2017; 20: 511–9.
    OpenUrl
  13. 13.↵
    2. Bao X,
    3. Duan JY,
    4. Yan YJ,
    5. Ma X,
    6. Zhang Y,
    7. Wang HF, et al.
    Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma. Cancer Biomark. 2017; 21: 55–63.
    OpenUrl
  14. 14.↵
    2. Kong R,
    3. Zhang EB,
    4. Yin DD,
    5. You LH,
    6. Xu TP,
    7. Chen WM, et al.
    Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16. Mol Cancer. 2015; 14: 82.
    OpenUrlCrossRefPubMed
  15. 15.↵
    2. Wang F,
    3. Yuan JH,
    4. Wang SB,
    5. Yang F,
    6. Yuan SX,
    7. Ye C, et al.
    Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatology. 2014; 60: 1278–90.
    OpenUrlCrossRefPubMed
  16. 16.↵
    2. Ørom UA,
    3. Derrien T,
    4. Beringer M,
    5. Gumireddy K,
    6. Gardini A,
    7. Bussotti G, et al.
    Long noncoding RNAs with enhancer-like function in human cells. Cell. 2010; 143: 46–58.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    2. Fang XY,
    3. Pan HF,
    4. Leng RX,
    5. Ye DQ.
    Long noncoding RNAs: novel insights into gastric cancer. Cancer Lett. 2015; 356: 357–66.
    OpenUrlCrossRefPubMed
  18. 18.↵
    2. Zlotorynski E.
    Small RNAs: new microRNA-like molecules. Nat Rev Mol Cell Biol. 2016; 17: 396.
    OpenUrl
  19. 19.↵
    2. Svoronos AA,
    3. Engelman DM,
    4. Slack FJ.
    OncomiR or tumor suppressor? The duplicity of MicroRNAs in cancer. Cancer Res. 2016; 76: 3666–70.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    2. Zhang SR,
    3. Zhang GL,
    4. Liu JY.
    Long noncoding RNA PVT1 promotes cervical cancer progression through epigenetically silencing miR-200b. APMIS. 2016; 124: 649–58.
    OpenUrl
  21. 21.↵
    2. Takahashi Y,
    3. Sawada G,
    4. Kurashige J,
    5. Uchi R,
    6. Matsumura T,
    7. Ueo H, et al.
    Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. Br J Cancer. 2014; 110: 164–71.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    2. Yang H,
    3. Kong W,
    4. He L,
    5. Zhao JJ,
    6. O'Donnell JD,
    7. Wang J, et al.
    MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 2008; 68: 425–33.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    2. Xu ZY,
    3. Wang T.
    miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1. Biochem Biophys Res Commun. 2014; 449: 190–5.
    OpenUrlCrossRefPubMed
  24. 24.↵
    2. Deng M,
    3. Ye QR,
    4. Qin ZL,
    5. Zheng Y,
    6. He W,
    7. Tang HL, et al.
    miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma. Tumor Biol. 2013; 34: 1793–800.
    OpenUrl
  25. 25.↵
    2. Zhang LL,
    3. Guo YJ,
    4. Zhao CN,
    5. Gao JY.
    Effects and mechanism of miR-214 on hepatocellular carcinoma. Asian Pac J Trop Med. 2015; 8: 392–8.
    OpenUrl
  26. 26.↵
    2. Ma Y,
    3. Lu Y,
    4. Lu BJ.
    MicroRNA and long Non-coding RNA in ovarian carcinoma: translational insights and potential clinical applications. Cancer Invest. 2016; 34: 465–76.
    OpenUrl
  27. 27.↵
    2. Mitra R,
    3. Chen X,
    4. Greenawalt EJ,
    5. Maulik U,
    6. Jiang W,
    7. Zhao ZM, et al.
    Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition. Nat Commun. 2017; 8: 1604.
    OpenUrlPubMed
  28. 28.↵
    2. Shi J,
    3. Dong B,
    4. Cao JC,
    5. Mao JM,
    6. Guan W,
    7. Peng Y, et al.
    Long non-coding RNA in glioma: signaling pathways. Oncotarget. 2017; 8: 27582–92.
    OpenUrl
  29. 29.↵
    2. Liu B,
    3. Tian YF,
    4. Li F,
    5. Zhao ZR,
    6. Jiang X,
    7. Zhai CJ, et al.
    Tumor-suppressing roles of miR-214 and miR-218 in breast cancer. Oncol Rep. 2016; 35: 3178–84.
    OpenUrl
  30. 30.↵
    2. Long LM,
    3. He BF,
    4. Huang GQ,
    5. Guo YH,
    6. Liu YS,
    7. Hou JR.
    microRNA-214 functions as a tumor suppressor in human colon cancer via the suppression of ADP-ribosylation factor-like protein 2. Oncol Lett. 2015; 9: 645–50.
    OpenUrl
  31. 31.↵
    2. Xin RJ,
    3. Bai FH,
    4. Feng YN,
    5. Jiu MN,
    6. Liu XG,
    7. Bai FY, et al.
    MicroRNA-214 promotes peritoneal metastasis through regulating PTEN negatively in gastric cancer. Clin Res Hepatol Gastroenterol. 2016; 40: 748–54.
    OpenUrl
  32. 32.↵
    2. Xu YH,
    3. Lu S.
    Regulation of β-catenin-mediated esophageal cancer growth and invasion by miR-214. Am J Transl Res. 2015; 7: 2316–25.
    OpenUrl
  33. 33.↵
    2. Long HX,
    3. Wang ZY,
    4. Chen JY,
    5. Xiang T,
    6. Li QJ,
    7. Diao XW, et al.
    microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu). Oncotarget. 2015; 6: 38705–18.
    OpenUrl
  34. 34.↵
    2. Yuan SX,
    3. Wang J,
    4. Yang F,
    5. Tao QF,
    6. Zhang J,
    7. Wang LL, et al.
    Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1. Hepatology. 2016; 63: 499–511.
    OpenUrlCrossRefPubMed
  35. 35.↵
    2. Guo J,
    3. Ma JQ,
    4. Zhao GS,
    5. Li GC,
    6. Fu YF,
    7. Luo YW, et al.
    Long noncoding RNA LINC0086 functions as a tumor suppressor in nasopharyngeal carcinoma by targeting miR-214. Oncol Res. 2017; 25: 1189–97.
    OpenUrlCrossRefPubMed
  36. 36.↵
    2. Shen Y,
    3. Liu SS,
    4. Yuan HY,
    5. Ying XM,
    6. Fu HJ,
    7. Zheng XF.
    A long non-coding RNA lncRNA-PE promotes invasion and epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-200a/b-ZEB1 pathway. Tumour Biol. 2017; 39: 1010428317705756.
    OpenUrl
  37. 37.↵
    2. Yuan JH,
    3. Yang F,
    4. Wang F,
    5. Ma JZ,
    6. Guo YJ,
    7. Tao QF, et al.
    A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014; 25: 666–81.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords